Impact of fulminant hepatic failure in C-reactive protein?

Journal of Critical Care

Volumn 25, Issue 4, 2010, Pages 657.e7-657.e12

  Silvestre, Joana Pedro da Silva ^a   Coelho, Luis Miguel da Cruz ^a   Póvoa, Pedro Manuel Sarmento Rodrigues ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

C reactive protein; Fulminant hepatic failure; Infection; Sepsis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; APACHE; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FULMINANT HEPATIC FAILURE; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; LENGTH OF STAY; LEUKOCYTE COUNT; LIVER FAILURE; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEPTIC SHOCK;

EID: 78649444953     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2010.02.004     Document Type: Article

References (29)

1. Polson J., Lee W.M. AASLD position paper: the management of acute liver failure. Hepatology (Baltimore, Md 2005, 41:1179-1197.
2. Polson J. Assessment of prognosis in acute liver failure. Semin Liver Dis 2008, 28:218-225.
3. Ostapowicz G., Fontana R.J., Schiodt F.V., Larson A., Davern T.J., Han S.H., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002, 137:947-954.
4. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448-454.
5. Adler M. Recent insights into pathophysiology of sepsis-associated liver dysfunction. Acta Gastroenterol Belg 2001, 64:314-317.
6. Fang C., Yoon S., Tindberg N., Jarvelainen H.A., Lindros K.O., Ingelman-Sundberg M. Hepatic expression of multiple acute phase proteins and down-regulation of nuclear receptors after acute endotoxin exposure. Biochem Pharmacol 2004, 67:1389-1397.
7. Ramadori G., Van Damme J., Rieder H., Meyer zum Buschenfelde K.H. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1beta and tumor necrosis factor-alpha. Eur J Immunol 1988, 18:1259-1264.
8. Szabo G., Romics L., Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 2002, 6:1045-1066. , x.
9. Izumi S., Hughes R.D., Langley P.G., Pernambuco J.R., Williams R. Extent of the acute phase response in fulminant hepatic failure. Gut 1994, 35:982-986.
10. Marnell L., Mold C., Du Clos T.W. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol (Orlando, Fla) 2005, 117:104-111.
11. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
12. Reeves G. C-reactive protein. Aust Prescr 2007, 30:74-76.
13. Vigushin D.M., Pepys M.B., Hawkins P.N. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993, 91:1351-1357.
14. Sierra R., Rello J., Bailen M.A., Benitez E., Gordillo A., Leon C., et al. C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome. Intensive Care Med 2004, 30:2038-2045.
15. Simon L., Gauvin F., Amre D.K., Saint-Louis P., Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39:206-217.
16. Trey C., Davidson C.S. The management of fulminant hepatic failure. Prog Liver Dis 1970, 3:282-298.
17. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
18. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
19. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
20. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
21. Duckert F. Behaviour of antithrombin 3 in liver disease. Scand J Gastroenterol Suppl 1973, 19:109-112.
22. Langley P.G., Williams R. Physiological inhibitors of coagulation in fulminant hepatic failure. Blood Coagul Fibrinolysis 1992, 3:243-247.
23. Le Moine O., Deviere J., Devaster J.M., Crusiaux A., Durand F., Bernuau J., et al. Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. J Hepatol 1994, 20:819-824.
24. Bota D.P., Van Nuffelen M., Zakariah A.N., Vincent J.L. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005, 146:347-351.
25. Rahman S.H., Evans J., Toogood G.J., Lodge P.A., Prasad K.R. Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure. Arch Surg 2008, 143:247-253. [discussion 253].
26. de Liguori Carino N., O'Reilly D.A., Dajani K., Ghaneh P., Poston G.J., Wu A.V. Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure. Eur J Surg Oncol 2009, 35:957-962.
27. Amour J., Birenbaum A., Langeron O., Le Manach Y., Bertrand M., Coriat P., et al. Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 2008, 36:1147-1154.
28. Dahaba A.A., Rehak P.H., List W.F. Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 2003, 29:579-583.
29. Salluh J.I., Fuks A.G. Corticosteroids in critically ill patients: a long and winding road. Arch Surg 2006, 141:945-947.